cbdMD
YCBD
51 hedge funds and large institutions have $4.05M invested in cbdMD in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
4% more funds holding
Funds holding: 49 → 51 (+2)
8% more call options, than puts
Call options by funds: $41K | Put options by funds: $38K
0% less ownership
Funds ownership: 0.05% → 0.04% (-0%)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
60% less capital invested
Capital invested by funds: $10M → $4.05M (-$5.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$208K |
| 2 |
Renaissance Technologies
New York
|
+$50.9K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$48.3K |
| 4 |
Millennium Management
New York
|
+$26.5K |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
+$16.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Merlin Capital
Newport,
Rhode Island
|
-$338K |
| 2 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
-$156K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$98.7K |
| 4 |
BlackRock
New York
|
-$55.2K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49.3K |
YCBD Hedge Fund Activity: Q2 2022 in Review
51 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q2 2022, worth a combined $4.05M — down 60% from $10M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new YCBD positions and 5 closed out — a net gain of 2 holders — while 12 added to existing stakes and 16 trimmed.
The largest buyer was Mirae Asset Global Investments, adding an estimated $208K. The largest seller was Merlin Capital, cutting an estimated $338K.
- 51 institutional investors held cbdMD (YCBD) as of Q2 2022, up from 49 in Q1 2022.
- Funds reported $4.05M of cbdMD stock for Q2 2022, down 60% quarter-over-quarter.
- 7 funds opened new cbdMD positions in Q2 2022 and 5 closed out, a net change of +2 holders.
- The largest cbdMD buyer in Q2 2022 was Mirae Asset Global Investments, an estimated $208K added.
- The largest cbdMD seller in Q2 2022 was Merlin Capital, an estimated $338K sold.
Based on aggregated 13F filings for Q2 2022.